Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Price Target

Price Target

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Barclays Maintains Overweight on Apple Hospitality REIT, Lowers Price Target to $19

By Benzinga Newsdesk
July 7, 6:57 AM
Barclays analyst Anthony Powell maintains Apple Hospitality REIT (NYSE:APLE) with a Overweight and lowers the price target from $21 to $19.

APLE

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Keybanc Maintains Overweight on AvidXchange Holdings, Lowers Price Target to $10

By Benzinga Newsdesk
July 7, 6:50 AM
Keybanc analyst Josh Beck maintains AvidXchange Holdings (NASDAQ:AVDX) with a Overweight and lowers the price target from $14 to $10.

AVDX

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Truist Securities Maintains Buy on Criteo, Lowers Price Target to $35

By Benzinga Newsdesk
July 7, 6:47 AM
Truist Securities analyst Matthew Thornton maintains Criteo (NASDAQ:CRTO) with a Buy and lowers the price target from $40 to $35.

CRTO

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Barclays Maintains Equal-Weight on RLJ Lodging, Lowers Price Target to $15

By Benzinga Newsdesk
July 7, 6:43 AM
Barclays analyst Anthony Powell maintains RLJ Lodging (NYSE:RLJ) with a Equal-Weight and lowers the price target from $18 to $15.

RLJ

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Barclays Maintains Overweight on Eli Lilly, Raises Price Target to $355

By Benzinga Newsdesk
July 7, 6:28 AM
Barclays analyst Geoff Meacham maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $333 to $355.

LLY

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Credit Suisse Maintains Neutral on MarketAxess Holdings, Lowers Price Target to $305

By Benzinga Newsdesk
July 7, 6:26 AM
Credit Suisse analyst Gautam Sawant maintains MarketAxess Holdings (NASDAQ:MKTX) with a Neutral and lowers the price target from $316 to $305.

MKTX

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

HC Wainwright & Co. Maintains Buy on Gold Royalty, Raises Price Target to $8.5

By Benzinga Newsdesk
July 7, 6:21 AM
HC Wainwright & Co. analyst Heiko Ihle maintains Gold Royalty (AMEX:GROY) with a Buy and raises the price target from $8.25 to $8.5.

GROY

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

UBS Downgrades Kellogg to Neutral, Lowers Price Target to $74

By Benzinga Newsdesk
July 7, 6:15 AM
UBS analyst Cody Ross downgrades Kellogg (NYSE:K) from Buy to Neutral and lowers the price target from $81 to $74.

K

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Upgrades

BTIG Upgrades 1Life Healthcare to Buy, Announces $15 Price Target

By Benzinga Newsdesk
July 7, 6:08 AM
BTIG analyst David Larsen upgrades 1Life Healthcare (NASDAQ:ONEM) from Neutral to Buy and announces $15 price target.

ONEM

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Upgrades

Daiwa Capital Upgrades Merck & Co to Outperform, Raises Price Target to $102

By Benzinga Newsdesk
July 7, 5:55 AM
Daiwa Capital analyst Narumi Nakagiri upgrades Merck & Co (NYSE:MRK) from Hold to Outperform and raises the price target from $89 to $102.

MRK

Posts pagination

Previous 1 … 2,138 2,139 2,140 … 2,160 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service